@article{ATM5399,
author = {Francesca Cannarile and Valentina Valentini and Giulia Mirabelli and Alessia Alunno and Riccardo Terenzi and Filippo Luccioli and Roberto Gerli and Elena Bartoloni},
title = {Cardiovascular disease in systemic sclerosis},
journal = {Annals of Translational Medicine},
volume = {3},
number = {1},
year = {2015},
keywords = {},
abstract = {Cardiovascular (CV) system involvement is a frequent complication of autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). It still remains unclear if a premature atherosclerosis (ATS) occurs even in systemic sclerosis (SSc). Although microvascular disease is a hallmark of SSc, in the last few years a number of studies highlighted a higher prevalence of macrovascular disease in SSc patients in comparison to healthy individuals and these data have been correlated with a poorer prognosis. The mechanisms promoting ATS in SSc are not fully understood, but it is believed to be secondary to multi-system organ inflammation, endothelial wall damage and vasculopathy. Both traditional risk factors and endothelial dysfunction have been proposed to participate to the onset and progression of ATS in such patients. In particular, endothelial cell injury induced by anti-endothelial antibodies, ischemia/reperfusion damage, immune-mediated cytotoxicity represent the main causes of vascular injury together with an impaired vascular repair mechanism that determine a defective vasculogenesis. Aim of this review is to analyse both causes and clinical manifestations of macrovascular involvement and ATS in SSc.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/5399}
}